Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Anne Goriely is an Associate Professor of Human Genetics at the Radcliffe Department of Medicine. Her award will support a research programme focusing on a process called selfish selection, promoting clonal expansion of pathogenic de novo mutations in human testes/male germline. De novo mutations are widely thought to occur randomly. However, the group has challenged this assumption by showing that so-called selfish mutations are able to hijack the cellular control of male germline stem cells in which they arise, leading to their preferential transmission to the next generation. The Goriely group will use state-of-the-art technology to assess the significance of selfish selection for human disease and genome evolution.

Many congratulation to Prof Goriely.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.